All Episodes

NEJM Interview: Prof. Timothy Jost on Trump’s effort to undermine the Affordable Care Act and Republican proposals to replace it.

NEJM Interview: Dr. Stuart Slavin on depression and suicide among physicians and trainees and how to address stigma associated with mental illness.

NEJM Interview: Dr. Andrew Goodman-Bacon on a proposal for setting limits on federal Medicaid spending and how it may affect access to care.

NEJM Interview: Dr. Michael Greene on a recent FDA warning about possible effects of general anesthesia on fetuses or young children.

NEJM Interview: Dr. Keith Wailoo on the medical and social context that has made progress in treating sickle cell disease slow and arduous.

NEJM Interview: Dr. Beau Kilmer on the effects of cannabis on health and how jurisdictions can minimize harms related to its legalization.

NEJM Interview: Dr. Richard Frank on the increasing number of deaths involving fentanyl in the United States.

NEJM Interview: Dr. Suerie Moon on recommendations from the United Nations Secretary General’s High-Level Panel on Access to Medicines.

NEJM Interview: Dr. John Ayanian on the economic benefits associated with Michigan’s decision to expand Medicaid.

NEJM Interview: Dr. Scott Halpern on whether cognitive function should be considered in decisions about organ allocation.

NEJM Interview: Dr. Vivian Lee on how physicians and health care systems can get the most out of sharing patient feedback.

NEJM Interview: Dr. Louise Ivers on cholera transmission and vaccination efforts in post-hurricane Haiti.

NEJM Interview: Dr. Jonathan Oberlander on what a Trump presidency could mean for the future of health care reform.

NEJM Interview: Dr. David Asch on the potential uses of social engagement strategies in promoting health.

NEJM Interview: Dr. Vivek Murthy on his campaign to address opioid addiction and misuse in the United States.

NEJM Interview: Prof. Christopher Robertson on whether the First Amendment should protect sales pitches by pharmaceutical representatives.

NEJM Interview: Dr. J. Michael McWilliams on the merits of care coordination - and why it’s unlikely to reduce health care spending.

NEJM Interview: Dr. Stefan Kertesz on the success and evaluation of programs providing permanent supportive housing to homeless people.

NEJM Interview: Dr. Leemore Dafny on ways in which health care providers could undermine efforts to steer consumers toward high-value care.

NEJM Interview: Rachel Fabi on recent legislative measures to extend insurance coverage for undocumented immigrants in California.

NEJM Interview: Dr. David Rosenthal on the effect of the electronic era on physician satisfaction.

NEJM Interview: Dr. Kevin Schulman on intensive home health care as an alternative to hospitalization.

NEJM Interview: Dr. Thomas Lee on measures of health care quality that are most important to patients.

NEJM Interview: Dr. C. William Keck on an agreement between the United States and Cuba to cooperate on efforts to improve health.

NEJM Interview: Dr. Christine Montross on treatment and confinement of people with serious mental illness.

NEJM Interview: Dr. Paul Ginsburg on what the 2016 election will mean for health care reform.

NEJM Interview: Dr. Anthony Fauci on potential strategies for conducting clinical trials of Zika virus vaccines.

NEJM Interview: Dr. Jeffrey Drazen on the future of sharing clinical trial data.

NEJM Interview: Dr. Thomas Bodenheimer on the evolving roles of physicians and nurses in the provision of primary care.

NEJM Interview: Dr. David Blumenthal on approaches to caring for the 5% of patients who account for 50% of annual health care spending.

NEJM Interview: Prof. R. Alta Charo on the implications of the Whole Woman’s Health case and likely future anti-abortion strategies.

NEJM Interview: Dr. Richard Bohmer on the strategies of health care organizations that have successfully implemented continuous improvement.

Dr. Christopher Dale on better ways of deploying quality metrics to improve the value of health care.

Dr. Scott Podolsky on the evolution of the essential methods of randomized, controlled trials.

Dr. Harlan Krumholz on the movement toward broader, responsible, productive sharing of data from clinical trials.

Dr. Alan D.T. Barrett on the current yellow fever epidemic and lessons about vaccine supply and global health.

Dr. Benjamin Sommers on the future cost of insurance coverage under the Affordable Care Act.

Dr. Alisha Rankin on the clinical trials and drug approval processes of the 16th through 18th centuries.

Dr. Eric Rubin on the current state of the Zika epidemic and directions for research and prevention.

Dr. José Jerónimo on approaches to reducing rates of cervical cancer in low- and middle-income countries.

Dr. Jeffrey Drazen on evolving efforts to make clinical trials data accessible and useful for further research.

Dr. Ameet Sarpatwari on state bills that aim to reduce drug spending by requiring companies to disclose R&D costs.

NEJM Interview: Dr. Perri Klass on the health effects of child poverty in the United States and the AAP’s new policy statement on screening.

NEJM Interview: Dr. Jeffrey Drazen on a new article series, The Changing Face of Clinical Trials.

NEJM Interview: Dr. Deborah Schrag on an experiment testing new ways of reimbursing physicians for drugs administered under Medicare Part B.

NEJM Interview: Dr. Alice Shaw on a new model for accelerating the development of promising oncology drugs.

NEJM Interview: Greg Simon on the National Cancer Moonshot Initiative and its goal of fueling cancer research in the United States.

NEJM Interview: Dr. Lindsey Baden on the state of the Zika virus outbreak and the challenges involved in containing it.

NEJM Interview: Robert Mechanic on what happens when patients are treated by multiple providers participating in different Medicare payment models.

NEJM Interview: Dr. Michelle Mello on legislation aimed at reducing young people’s access to cigarettes.

NEJM Interview: Dr. Debra Houry on a new opioid-prescribing guideline from the Centers for Disease Control and Prevention.

NEJM Interview: Dr. Jonathan Oberlander on the renewed interest in single-payer health insurance and its prospects in the United States.

NEJM Interview: Dr. Amy Fairchild on public health recommendations regarding electronic cigarettes in England and the United States.

NEJM Interview: Dr. Ronald Paulus on a program at his health system for educating board members about care delivery.

NEJM Interview: Dr. David Bellinger on lead contamination in Flint, Michigan, and the lack of political will to protect public health.

NEJM Interview: Dr. Ashish Jha on lessons from the recent Veterans Health Administration crisis and future directions at the VA.

NEJM Interview: Prof. R. Alta Charo on recent advances in gene editing and concerns about medical tourism.

NEJM Interview: Cecile Richards on expanding access to birth control and threats to that progress.

NEJM Interview: Dr. Rena Conti on policy proposals that could help rein in the cost of prescription drugs.

NEJM Interview: Dr. Robert Galvin on the effects of the Affordable Care Act on employer-sponsored insurance.

NEJM Interview: Dr. Walter Orenstein on the final steps in the global effort to eradicate polio.

NEJM Interview: Dr. Steven DeKosky on youth football, head injuries, and a recent American Academy of Pediatrics policy statement.

NEJM Interview: Dr. Daniel Alford on how prescriber education can help address the epidemic of prescription-opioid misuse.

NEJM Interview: Dr. Scott Podolsky on the history of weak oversight of homeopathic remedies in the United States and what the future may hold.

NEJM Interview: Dr. Terri Fried on different approaches to shared decision making driven by different clinical circumstances.

NEJM Interview: Prof. Timothy Jost on a lawsuit brought by the House of Representatives over the Affordable Care Act’s cost-sharing-reduction program.

NEJM Interview: Dr. Peter Neumann on the use of various new value-based frameworks for assessing drugs and drug prices.

NEJM Interview: Dr. Michele Heisler on attacks on physicians and health care facilities in Syria and the response from the international community.

NEJM Interview: Dr. Charlotte Haug on the growing number of article retractions attributable to peer-review fraud.

NEJM Interview: Prof. Alexander Capron on proposed changes to regulations governing human-subjects research.

NEJM Interview: Dr. Anthony Fauci on the ways in which new evidence has improved our strategies for treating and preventing HIV infection.

NEJM Interview: Dr. David Courtwright on a 19th-century epidemic of opiate addiction and its lessons for the current crisis.

NEJM Interview: Dr. Paul Ginsburg on how Medicare can improve care delivery and control spending going forward.

NEJM Interview: Dr. Michael Lauer on peer review of NIH grant applications and how it can be improved.

NEJM Interview: Dr. Fitzhugh Mullan on trends in the numbers of U.S. medical school graduates and GME positions.

NEJM Interview: Dr. H. Gilbert Welch on trends in the incidence of metastatic cancers and their implications for both screening and our understanding of cancer.

NEJM Interview: Dr. Kevin Schulman on the recent approval of two PCSK9 inhibitors and what their prices could mean for insurance premiums.

NEJM Interview: Drs. Allan Goroll and Ateev Mehrotra on whether the annual physical should be retained, eliminated, or modified for 21st-century realities.

NEJM Interview: Dr. David Urbach on a plan to concentrate certain surgical procedures among the physicians and hospitals that perform the most of them.

NEJM Interview: Dr. Michael Fiore on the potential for regulation of nicotine levels in cigarettes to help smokers quit.

NEJM Interview: Dr. Jonathan Oberlander on the outlook for Medicare’s new physician payment system.

NEJM Interview: Dr. Christopher Robertson on the FDA’s new draft guidelines on direct-to-consumer pharmaceutical advertising.

NEJM Interview: Dr. Hermes Taylor-Weiner on the regulation of stem-cell clinics offering unproven therapies.

NEJM Interview: Dr. Georgina Peacock on improvements in care and access to services for people with disabilities and where more work is needed.

NEJM Interview: Dr. Michelle Mello on a new California law that eliminates religious and philosophical exemptions for vaccination mandates.

NEJM Interview: Dr. Philip Landrigan on health concerns associated with genetically modified crops and the herbicides used on them.

NEJM Interview: Dr. David Asch on strategies for testing new ideas in health care quickly and efficiently.

NEJM Interview: Dr. Ronald Bayer on why the heightened focus on precision medicine misses the point when it comes to public health.

NEJM Interview: Dr. Steffanie Strathdee on needle-exchange policies and the recent HIV outbreak in rural Indiana.

NEJM Interview: Dr. Stanley Plotkin on a strategy for stimulating and supporting global vaccine research.

NEJM Interview: Prof. Amy Kapczynski on provisions in the Trans-Pacific Partnership that could affect access to drugs in the United States and abroad.

NEJM Interview: Dr. Joshua Sharfstein on the process of approving new sunscreen ingredients for marketing in the United States.

NEJM Interview: Prof. Ted Kaptchuk on the outlook for harnessing the benefits of placebo effects in medicine.

NEJM Interview: Dr. Jerry Avorn on the 21st Century Cures Act’s potential implications for drug development and safety.

NEJM Interview: Dr. Aaron Kesselheim on the challenges of bringing follow-on biologic drugs to the market.

NEJM Interview: Dr. Dhruv Khullar on uses of behavioral economics concepts in modifying physicians’ behavior under value-based health care models.

NEJM Interview: Dr. Neel Shah on new guidelines from the United Kingdom on the safety of midwife-guided deliveries.

NEJM Interview: Prof. Leemore Dafny on ways of producing health care mergers that are good for both patients and providers.

NEJM Interview: Dr. Henry Aaron on new legislation that reforms physician reimbursement under Medicare.

NEJM Interview: Dr. Jerry Avorn on a new estimate of the cost of bringing a drug to market.